Nitric oxide synthases in heart failure.

SIGNIFICANCE The regulation of myocardial function by constitutive nitric oxide synthases (NOS) is important for the maintenance of myocardial Ca(2+) homeostasis, relaxation and distensibility, and protection from arrhythmia and abnormal stress stimuli. However, sustained insults such as diabetes, hypertension, hemodynamic overload, and atrial fibrillation lead to dysfunctional NOS activity with superoxide produced instead of NO and worse pathophysiology. RECENT ADVANCES Major strides in understanding the role of normal and abnormal constitutive NOS in the heart have revealed molecular targets by which NO modulates myocyte function and morphology, the role and nature of post-translational modifications of NOS, and factors controlling nitroso-redox balance. Localized and differential signaling from NOS1 (neuronal) versus NOS3 (endothelial) isoforms are being identified, as are methods to restore NOS function in heart disease. CRITICAL ISSUES Abnormal NOS signaling plays a key role in many cardiac disorders, while targeted modulation may potentially reverse this pathogenic source of oxidative stress. FUTURE DIRECTIONS Improvements in the clinical translation of potent modulators of NOS function/dysfunction may ultimately provide a powerful new treatment for many hearts diseases that are fueled by nitroso-redox imbalance.

[1]  K. Andrews,et al.  Arginase II inhibition prevents nitrate tolerance , 2012, British journal of pharmacology.

[2]  J. Jang,et al.  Neuronal nitric oxide synthase is up-regulated by angiotensin II and attenuates NADPH oxidase activity and facilitates relaxation in murine left ventricular myocytes. , 2012, Journal of molecular and cellular cardiology.

[3]  U. Laufs,et al.  Endothelial nitric oxide synthase of the bone marrow regulates myocardial hypertrophy, fibrosis, and angiogenesis. , 2012, Cardiovascular research.

[4]  D. Kass,et al.  Preconditioning by Phosphodiesterase‐5 Inhibition Improves Therapeutic Efficacy of Adipose‐Derived Stem Cells Following Myocardial Infarction in Mice , 2012, Stem cells.

[5]  P. Vardas,et al.  Effects of the long‐term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study , 2012, European journal of heart failure.

[6]  D. Kass,et al.  Pressure-Overload–Induced Subcellular Relocalization/Oxidation of Soluble Guanylyl Cyclase in the Heart Modulates Enzyme Stimulation , 2012, Circulation research.

[7]  K. Channon,et al.  Myocardial redox state predicts in-hospital clinical outcome after cardiac surgery effects of short-term pre-operative statin treatment. , 2012, Journal of the American College of Cardiology.

[8]  A. Alkilany,et al.  Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway , 2012, British journal of pharmacology.

[9]  S. Jha,et al.  Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation. , 2011, Journal of the American College of Cardiology.

[10]  J. Stamler,et al.  Regulation by S-Nitrosylation of Protein Post-translational Modification* , 2011, The Journal of Biological Chemistry.

[11]  M. Whiteman,et al.  Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools. , 2011, Clinical science.

[12]  P. Eaton,et al.  Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension , 2011, Nature Medicine.

[13]  T. Iwasaka,et al.  Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction. , 2011, American journal of physiology. Heart and circulatory physiology.

[14]  X. Tian,et al.  Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice. , 2011, Cardiovascular research.

[15]  P. Mehta,et al.  Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: role for CAPON and Ang II. , 2011, Cardiovascular research.

[16]  D. Kass,et al.  Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failure. , 2011, Journal of molecular and cellular cardiology.

[17]  D. Kass,et al.  Targeting endothelial and myocardial dysfunction with tetrahydrobiopterin. , 2011, Journal of molecular and cellular cardiology.

[18]  M. Bonini,et al.  NOS-1-derived NO is an essential triggering signal for the development of systemic inflammatory responses. , 2011, European journal of pharmacology.

[19]  M. Kavdia,et al.  Modeling of biopterin-dependent pathways of eNOS for nitric oxide and superoxide production. , 2011, Free radical biology & medicine.

[20]  Hang Lu,et al.  Betulinic acid ameliorates endothelium-dependent relaxation in L-NAME-induced hypertensive rats by reducing oxidative stress , 2011, Heart.

[21]  A. Banday,et al.  Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. , 2011, European journal of pharmacology.

[22]  Michael D. Pluth,et al.  Hydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis , 2011, Proceedings of the National Academy of Sciences.

[23]  U. Schotten,et al.  Atrial Sources of Reactive Oxygen Species Vary With the Duration and Substrate of Atrial Fibrillation: Implications for the Antiarrhythmic Effect of Statins , 2011, Circulation.

[24]  Arthur J. L. Cooper,et al.  Reversible and irreversible protein glutathionylation: biological and clinical aspects , 2011, Expert opinion on drug metabolism & toxicology.

[25]  J. Zweier,et al.  Superoxide Induces Endothelial Nitric-oxide Synthase Protein Thiyl Radical Formation, a Novel Mechanism Regulating eNOS Function and Coupling* , 2011, The Journal of Biological Chemistry.

[26]  A. Hale,et al.  Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency , 2011, Free radical biology & medicine.

[27]  P. Insel,et al.  Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling. , 2011, Journal of the American College of Cardiology.

[28]  J. Cheung,et al.  Left ventricular dysfunction in murine models of heart failure and in failing human heart is associated with a selective decrease in the expression of caveolin-3. , 2011, Journal of cardiac failure.

[29]  M. W. Vogel,et al.  Novel Natriuretic Peptides: New Compounds and New Approaches , 2011, Current heart failure reports.

[30]  M. Gucek,et al.  Simultaneous Measurement of Protein Oxidation and S-Nitrosylation During Preconditioning and Ischemia/Reperfusion Injury With Resin-Assisted Capture , 2011, Circulation research.

[31]  D. Julian,et al.  Hydrogen Sulfide Increases Nitric Oxide Production from Endothelial Cells by an Akt-Dependent Mechanism , 2011, Front. Physio..

[32]  J. Balligand,et al.  Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade. , 2011, Journal of the American College of Cardiology.

[33]  R. Arena,et al.  PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart Failure: Results of a 1-Year, Prospective, Randomized, Placebo-Controlled Study , 2011, Circulation. Heart failure.

[34]  Saisudha Koka,et al.  Attenuation of Doxorubicin-induced Cardiotoxicity by Tadalafil: A Long Acting Phosphodiesterase-5 Inhibitor. , 2010, Molecular and cellular pharmacology.

[35]  J. Zweier,et al.  S-glutathionylation uncouples eNOS and regulates its cellular and vascular function , 2010, Nature.

[36]  W. Paulus,et al.  The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature , 2010, European journal of heart failure.

[37]  P. Nordbeck,et al.  Conditional Overexpression of Neuronal Nitric Oxide Synthase Is Cardioprotective in Ischemia/Reperfusion , 2010, Circulation.

[38]  J. Beavo,et al.  Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy , 2010, Proceedings of the National Academy of Sciences.

[39]  G. Nasr,et al.  Allopurinol and global left myocardial function in heart failure patients , 2010, Journal of cardiovascular disease research.

[40]  U. Förstermann,et al.  Resveratrol Reverses Endothelial Nitric-Oxide Synthase Uncoupling in Apolipoprotein E Knockout Mice , 2010, Journal of Pharmacology and Experimental Therapeutics.

[41]  J. Corbin,et al.  cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action , 2010, Pharmacological Reviews.

[42]  S. Viatchenko‐Karpinski,et al.  Regulation of myocyte contraction via neuronal nitric oxide synthase: role of ryanodine receptor S‐nitrosylation , 2010, The Journal of physiology.

[43]  N. Stergiopulos,et al.  Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension. , 2010, Cardiovascular research.

[44]  F. Grimminger,et al.  Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study , 2010, European Respiratory Journal.

[45]  J. Pearson Endothelial progenitor cells--an evolving story. , 2010, Microvascular research.

[46]  Paul L Huang,et al.  Golgi and sarcolemmal neuronal NOS differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscle. , 2010, The Journal of clinical investigation.

[47]  S. Dikalov,et al.  Uncoupled Cardiac Nitric Oxide Synthase Mediates Diastolic Dysfunction , 2010, Circulation.

[48]  F. Sotgia,et al.  Caveolinopathies: from the biology of caveolin-3 to human diseases , 2010, European Journal of Human Genetics.

[49]  Dong I. Lee,et al.  PDE5A suppression of acute β-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation , 2010, Basic Research in Cardiology.

[50]  J. Hare,et al.  Cardiac nitric oxide synthase-1 localization within the cardiomyocyte is accompanied by the adaptor protein, CAPON. , 2009, Nitric oxide : biology and chemistry.

[51]  M. Crabtree,et al.  Dihydrofolate reductase and biopterin recycling in cardiovascular disease. , 2009, Journal of molecular and cellular cardiology.

[52]  Douglas L. Jones,et al.  Neuronal Nitric Oxide Synthase Protects Against Myocardial Infarction–Induced Ventricular Arrhythmia and Mortality in Mice , 2009, Circulation.

[53]  A. Shoukas,et al.  Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. , 2009, Journal of applied physiology.

[54]  J. Stamler,et al.  Protein S-nitrosylation in health and disease: a current perspective. , 2009, Trends in molecular medicine.

[55]  F. Atienza,et al.  Nitric Oxide Increases Cardiac IK1 by Nitrosylation of Cysteine 76 of Kir2.1 Channels , 2009, Circulation research.

[56]  Mark J. Kohr,et al.  Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytes. , 2009, Journal of molecular and cellular cardiology.

[57]  Jun Zhang,et al.  Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability. , 2009, American journal of physiology. Heart and circulatory physiology.

[58]  H. Otani The role of nitric oxide in myocardial repair and remodeling. , 2009, Antioxidants & redox signaling.

[59]  A. Shah,et al.  Effects of Neuronal Nitric Oxide Synthase on Human Coronary Artery Diameter and Blood Flow In Vivo , 2009, Circulation.

[60]  B. Levy,et al.  Tetrahydrobiopterin Recycling, a Key Determinant of Endothelial Nitric-oxide Synthase-dependent Signaling Pathways in Cultured Vascular Endothelial Cells* , 2009, Journal of Biological Chemistry.

[61]  Dimitris Tousoulis,et al.  Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. , 2009, European heart journal.

[62]  J. Stamler,et al.  Endogenous S-nitrosothiols protect against myocardial injury , 2009, Proceedings of the National Academy of Sciences.

[63]  T. Rea,et al.  Genetic Variations in Nitric Oxide Synthase 1 Adaptor Protein Are Associated With Sudden Cardiac Death in US White Community-Based Populations , 2009, Circulation.

[64]  B. Mayer,et al.  Mitochondrial nitrite reduction coupled to soluble guanylate cyclase activation: lack of evidence for a role in the bioactivation of nitroglycerin. , 2009, Nitric oxide : biology and chemistry.

[65]  D. Kass,et al.  Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload. , 2009, Journal of the American College of Cardiology.

[66]  A. Hale,et al.  Quantitative Regulation of Intracellular Endothelial Nitric-oxide Synthase (eNOS) Coupling by Both Tetrahydrobiopterin-eNOS Stoichiometry and Biopterin Redox Status , 2009, Journal of Biological Chemistry.

[67]  D. Paterson,et al.  Neuromodulators of peripheral cardiac sympatho‐vagal balance , 2009, Experimental physiology.

[68]  J. Tamargo,et al.  Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1). , 2008, Cardiovascular research.

[69]  G. Wensing,et al.  Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Activator Cinaciguat (BAY 58‐2667) in Healthy Male Volunteers , 2008, Journal of clinical pharmacology.

[70]  J. Zweier,et al.  Cardiac Myocyte–Specific Expression of Inducible Nitric Oxide Synthase Protects Against Ischemia/Reperfusion Injury by Preventing Mitochondrial Permeability Transition , 2008, Circulation.

[71]  J. Vasquez-Vivar,et al.  Deficient BH4 production via de novo and salvage pathways regulates NO responses to cytokines in adult cardiac myocytes. , 2008, American journal of physiology. Heart and circulatory physiology.

[72]  H. Shimokawa,et al.  Spontaneous myocardial infarction and nitric oxide synthase. , 2008, Trends in cardiovascular medicine.

[73]  D. Christianson,et al.  Arginase and vascular aging. , 2008, Journal of applied physiology.

[74]  J. Zweier,et al.  Phosphorylation of Endothelial Nitric-oxide Synthase Regulates Superoxide Generation from the Enzyme* , 2008, Journal of Biological Chemistry.

[75]  D. Thedens,et al.  Sarcolemma-localized nNOS is required to maintain activity after mild exercise , 2008, Nature.

[76]  J. Stamler,et al.  S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. , 2008, Molecular cell.

[77]  M. Bonini,et al.  Direct evidence of iNOS-mediated in vivo free radical production and protein oxidation in acetone-induced ketosis. , 2008, American journal of physiology. Endocrinology and metabolism.

[78]  D. Tester,et al.  Syntrophin mutation associated with long QT syndrome through activation of the nNOS–SCN5A macromolecular complex , 2008, Proceedings of the National Academy of Sciences.

[79]  C. Klinge,et al.  Resveratrol stimulates nitric oxide production by increasing estrogen receptor αa‐Src‐caveolin‐1 interaction and phosphorylation in human umbilical vein endothelial cells , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[80]  Joanne Brown,et al.  Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. , 2008, Journal of the American College of Cardiology.

[81]  L. Ignarro Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol. , 2008, Cardiovascular therapeutics.

[82]  P. Janssen,et al.  Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban. , 2008, American journal of physiology. Cell physiology.

[83]  James B. Mitchell,et al.  Reversal of Cardiac Hypertrophy and Fibrosis From Pressure Overload by Tetrahydrobiopterin: Efficacy of Recoupling Nitric Oxide Synthase as a Therapeutic Strategy , 2008, Circulation.

[84]  D. Kass,et al.  Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease. , 2008, American journal of physiology. Heart and circulatory physiology.

[85]  U. Förstermann,et al.  Antiatherosclerotic Effects of Small-Molecular-Weight Compounds Enhancing Endothelial Nitric-Oxide Synthase (eNOS) Expression and Preventing eNOS Uncoupling , 2008, Journal of Pharmacology and Experimental Therapeutics.

[86]  Y. Sasaguri,et al.  Spontaneous Myocardial Infarction in Mice Lacking All Nitric Oxide Synthase Isoforms , 2008, Circulation.

[87]  A. Shah,et al.  Neuronal Nitric Oxide Synthase Regulates Basal Microvascular Tone in Humans In Vivo , 2008, Circulation.

[88]  E. Marbán,et al.  CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart , 2008, Proceedings of the National Academy of Sciences.

[89]  J. Zweier,et al.  Dose dependent effects of reactive oxygen and nitrogen species on the function of neuronal nitric oxide synthase. , 2008, Archives of biochemistry and biophysics.

[90]  F. Gao,et al.  IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[91]  Mark J. Kohr,et al.  Endothelial nitric oxide synthase decreases beta-adrenergic responsiveness via inhibition of the L-type Ca2+ current. , 2008, American journal of physiology. Heart and circulatory physiology.

[92]  F. Zara,et al.  Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro , 2008, Laboratory Investigation.

[93]  M. Guazzi,et al.  Endothelium‐mediated Modulation of Ergoreflex and Improvement in Exercise Ventilation by Acute Sildenafil in Heart Failure Patients , 2008, Clinical pharmacology and therapeutics.

[94]  Z. Giricz,et al.  Cardiac capsaicin‐sensitive sensory nerves regulate myocardial relaxation via S‐nitrosylation of SERCA: role of peroxynitrite , 2008, British journal of pharmacology.

[95]  E. Kranias,et al.  Reduced Phospholamban Phosphorylation Is Associated With Impaired Relaxation in Left Ventricular Myocytes From Neuronal NO Synthase–Deficient Mice , 2008, Circulation research.

[96]  Anindita Das,et al.  Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[97]  J. Hare,et al.  Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes , 2007, Proceedings of the National Academy of Sciences.

[98]  D. Harrison,et al.  Regulation of Tetrahydrobiopterin Biosynthesis by Shear Stress , 2007, Circulation research.

[99]  G. Lembo,et al.  Nebivolol Induces Nitric Oxide Release in the Heart Through Inducible Nitric Oxide Synthase Activation , 2007, Hypertension.

[100]  J. Zweier,et al.  Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4 , 2007, Proceedings of the National Academy of Sciences.

[101]  J. P. Brennan,et al.  Cysteine Redox Sensor in PKGIa Enables Oxidant-Induced Activation , 2007, Science.

[102]  M. Mongillo,et al.  Protein Kinase G Phosphorylates Cav1.2 α1c and β2 Subunits , 2007, Circulation research.

[103]  U. Förstermann,et al.  Reciprocal Regulation of Endothelial Nitric-Oxide Synthase and NADPH Oxidase by Betulinic Acid in Human Endothelial Cells , 2007, Journal of Pharmacology and Experimental Therapeutics.

[104]  T. Meinertz,et al.  Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation. , 2007, Journal of molecular and cellular cardiology.

[105]  Matthew W. Foster,et al.  Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2 , 2007, Cell.

[106]  M. Picard,et al.  Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload. , 2007, American journal of physiology. Heart and circulatory physiology.

[107]  P. Vallance,et al.  Disruption of methylarginine metabolism impairs vascular homeostasis , 2007, Nature Medicine.

[108]  E. Cartwright,et al.  Neuronal Nitric Oxide Synthase Signaling in the Heart Is Regulated by the Sarcolemmal Calcium Pump 4b , 2007, Circulation.

[109]  G. Baumann,et al.  Abstract 325: Alternative Splicing in Intron 13 of the Human eNOS Gene: A Potential Mechanism for Regulating eNOS Activity , 2006 .

[110]  J. Tamargo,et al.  Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism. , 2006, Cardiovascular research.

[111]  R. Brandes,et al.  Nebivolol Inhibits Superoxide Formation by NADPH Oxidase and Endothelial Dysfunction in Angiotensin II–Treated Rats , 2006, Hypertension.

[112]  B. Rozec,et al.  beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. , 2006, Pharmacology & therapeutics.

[113]  R. Schwinger,et al.  ENOS is not activated by nebivolol in human failing myocardium. , 2006, Life sciences.

[114]  Mark A Sussman,et al.  Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy , 2006, Proceedings of the National Academy of Sciences.

[115]  A. Marx,et al.  Atheroprotective Effects of Neuronal Nitric Oxide Synthase in Apolipoprotein E Knockout Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[116]  Christian Gieger,et al.  A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization , 2006, Nature Genetics.

[117]  B. Casadei,et al.  Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation. , 2006, Cardiovascular research.

[118]  H. Masuda,et al.  Estradiol Enhances Recovery After Myocardial Infarction by Augmenting Incorporation of Bone Marrow–Derived Endothelial Progenitor Cells Into Sites of Ischemia-Induced Neovascularization via Endothelial Nitric Oxide Synthase–Mediated Activation of Matrix Metalloproteinase-9 , 2006, Circulation.

[119]  A. Shoukas,et al.  Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[120]  Irfan Rahman,et al.  Redox modifications of protein-thiols: emerging roles in cell signaling. , 2006, Biochemical pharmacology.

[121]  D. Bers,et al.  Hypercontractile Female Hearts Exhibit Increased S-Nitrosylation of the L-Type Ca2+ Channel &agr;1 Subunit and Reduced Ischemia/Reperfusion Injury , 2006, Circulation research.

[122]  R. Saraiva,et al.  Xanthine Oxidoreductase Inhibition Causes Reverse Remodeling in Rats With Dilated Cardiomyopathy , 2006, Circulation research.

[123]  T. Münzel,et al.  Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure. , 2005, Biochemical and biophysical research communications.

[124]  S. Neubauer,et al.  nNOS Gene Deletion Exacerbates Pathological Left Ventricular Remodeling and Functional Deterioration After Myocardial Infarction , 2005, Circulation.

[125]  R. Saraiva,et al.  Deficiency of Neuronal Nitric Oxide Synthase Increases Mortality and Cardiac Remodeling After Myocardial Infarction: Role of Nitroso-Redox Equilibrium , 2005, Circulation.

[126]  H. Shimokawa,et al.  Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans. , 2005, Journal of pharmacological sciences.

[127]  D. Kass,et al.  Reduced Wall Compliance Suppresses Akt-Dependent Apoptosis Protection Stimulated by Pulse Perfusion , 2005, Circulation research.

[128]  C. Schöneich,et al.  3-Nitrotyrosine modification of SERCA2a in the aging heart: a distinct signature of the cellular redox environment. , 2005, Biochemistry.

[129]  H. Cai,et al.  Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[130]  A. Zeiher,et al.  Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload. , 2005, Cardiovascular research.

[131]  Z. Gąsior,et al.  Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study , 2005, European journal of heart failure.

[132]  D. Kass,et al.  Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. , 2005, The Journal of clinical investigation.

[133]  S. Yusuf,et al.  Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. , 2005, JAMA.

[134]  T. Asahara,et al.  Endothelial Progenitor Cells Are Rapidly Recruited to Myocardium and Mediate Protective Effect of Ischemic Preconditioning via “Imported” Nitric Oxide Synthase Activity , 2005, Circulation.

[135]  K. Channon,et al.  Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. , 2005, Cardiovascular research.

[136]  A. Ahluwalia,et al.  Autoregulatory Role of Endothelium-derived Nitric Oxide (NO) on Lipopolysaccharide-induced Vascular Inducible NO Synthase Expression and Function* , 2005, Journal of Biological Chemistry.

[137]  A. Cohen-Solal,et al.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). , 2005, European heart journal.

[138]  B. Mayer,et al.  Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitroglycerin: evidence for the activation of purified soluble guanylate cyclase through direct formation of nitric oxide. , 2005, The Biochemical journal.

[139]  D. Kass,et al.  Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy , 2005, Nature Medicine.

[140]  J. Hare Nitroso-redox balance in the cardiovascular system. , 2004, The New England journal of medicine.

[141]  Ralph D'Agostino,et al.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. , 2004, The New England journal of medicine.

[142]  J. Hare,et al.  Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[143]  X. Loyer,et al.  Role of Myocardial Neuronal Nitric Oxide Synthase–Derived Nitric Oxide in &bgr;-Adrenergic Hyporesponsiveness After Myocardial Infarction–Induced Heart Failure in Rat , 2004, Circulation.

[144]  H. Drexler,et al.  Statin-Induced Improvement of Endothelial Progenitor Cell Mobilization, Myocardial Neovascularization, Left Ventricular Function, and Survival After Experimental Myocardial Infarction Requires Endothelial Nitric Oxide Synthase , 2004, Circulation.

[145]  D. Webb,et al.  Nebivolol Increases Arterial Distensibility In Vivo , 2004, Hypertension.

[146]  L. Nelin,et al.  Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[147]  F. Van de Werf,et al.  Cardiomyocyte-Specific Overexpression of Nitric Oxide Synthase 3 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction , 2004, Circulation research.

[148]  A. Shah,et al.  Increased neuronal nitric oxide synthase-derived NO production in the failing human heart , 2004, The Lancet.

[149]  E. Ziff,et al.  Bidirectional Regulation of Neuronal Nitric-oxide Synthase Phosphorylation at Serine 847 by the N-Methyl-d-aspartate Receptor* , 2004, Journal of Biological Chemistry.

[150]  P. Boysen,et al.  Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERK. , 2004, American journal of physiology. Heart and circulatory physiology.

[151]  H. Maeda,et al.  Pivotal role of Cu,Zn-superoxide dismutase in endothelium-dependent hyperpolarization. , 2003, The Journal of clinical investigation.

[152]  T. Sawamura,et al.  Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation. , 2003, Journal of the American College of Cardiology.

[153]  K. Pritchard,et al.  Phosphorylation of Threonine 497 in Endothelial Nitric-oxide Synthase Coordinates the Coupling of l-Arginine Metabolism to Efficient Nitric Oxide Production* , 2003, Journal of Biological Chemistry.

[154]  K. Channon,et al.  A Myocardial Nox2 Containing NAD(P)H Oxidase Contributes to Oxidative Stress in Human Atrial Fibrillation , 2003, Circulation research.

[155]  A. Shoukas,et al.  Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels , 2003, Circulation.

[156]  C. Heeschen,et al.  Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells , 2003, Nature Medicine.

[157]  T. Damy,et al.  Up‐regulation of cardiac nitric oxide synthase 1‐derived nitric oxide after myocardial infarction in senescent rats , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[158]  K. Rockett,et al.  Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. , 2003, The Journal of clinical investigation.

[159]  Shinichiro Yamamoto,et al.  Hydrogen peroxide stimulates tetrahydrobiopterin synthesis through the induction of GTP-cyclohydrolase I and increases nitric oxide synthase activity in vascular endothelial cells. , 2003, Free radical biology & medicine.

[160]  F. Salloum,et al.  Sildenafil Induces Delayed Preconditioning Through Inducible Nitric Oxide Synthase–Dependent Pathway in Mouse Heart , 2003, Circulation research.

[161]  Steven P Jones,et al.  Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[162]  E. Ashley,et al.  Cardiac Neuronal Nitric Oxide Synthase Isoform Regulates Myocardial Contraction and Calcium Handling , 2003, Circulation research.

[163]  Y. Hattori,et al.  HMG-CoA Reductase Inhibitor Increases GTP Cyclohydrolase I mRNA and Tetrahydrobiopterin in Vascular Endothelial Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[164]  D. Paterson,et al.  Enhanced neuronal nitric oxide synthase expression is central to cardiac vagal phenotype in exercise‐trained mice , 2003, The Journal of physiology.

[165]  B. Kalyanaraman,et al.  The Role of Tetrahydrobiopterin in Superoxide Generation from eNOS: Enzymology and Physiological Implications , 2003, Free radical research.

[166]  F. Grosveld,et al.  Reduction of Blood Pressure, Plasma Cholesterol, and Atherosclerosis by Elevated Endothelial Nitric Oxide* , 2002, The Journal of Biological Chemistry.

[167]  D. Harrison,et al.  Vascular Oxidative Stress and Endothelial Dysfunction in Patients With Chronic Heart Failure: Role of Xanthine-Oxidase and Extracellular Superoxide Dismutase , 2002, Circulation.

[168]  Xiangru Lu,et al.  Deficiency in endothelial nitric oxide synthase impairs myocardial angiogenesis. , 2002, American journal of physiology. Heart and circulatory physiology.

[169]  A. Goette,et al.  Downregulation of Endocardial Nitric Oxide Synthase Expression and Nitric Oxide Production in Atrial Fibrillation: Potential Mechanisms for Atrial Thrombosis and Stroke , 2002, Circulation.

[170]  David S. Park,et al.  Caveolin-3 Knock-out Mice Develop a Progressive Cardiomyopathy and Show Hyperactivation of the p42/44 MAPK Cascade* , 2002, The Journal of Biological Chemistry.

[171]  S. Rajagopalan,et al.  Altered Tetrahydrobiopterin Metabolism in Atherosclerosis: Implications for Use of Oxidized Tetrahydrobiopterin Analogues and Thiol Antioxidants , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[172]  U. Förstermann,et al.  Resveratrol, a Polyphenolic Phytoalexin Present in Red Wine, Enhances Expression and Activity of Endothelial Nitric Oxide Synthase , 2002, Circulation.

[173]  S. Daff,et al.  Calmodulin Activates Electron Transfer through Neuronal Nitric-oxide Synthase Reductase Domain by Releasing an NADPH-dependent Conformational Lock* , 2002, The Journal of Biological Chemistry.

[174]  E. Ashley,et al.  Cardiac Nitric Oxide Synthase 1 Regulates Basal and &bgr;-Adrenergic Contractility in Murine Ventricular Myocytes , 2002, Circulation.

[175]  J. Stamler,et al.  Identification of the enzymatic mechanism of nitroglycerin bioactivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[176]  P. Ping,et al.  Nitric Oxide (NO) Induces Nitration of Protein Kinase Cε (PKCε), Facilitating PKCε Translocation via Enhanced PKCε-RACK2 Interactions , 2002, The Journal of Biological Chemistry.

[177]  A. Shah,et al.  Role of cyclic GMP‐dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes , 2002, The Journal of physiology.

[178]  Joao A. C. Lima,et al.  Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. , 2002 .

[179]  J. Joseph,et al.  The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. , 2002, The Biochemical journal.

[180]  R. Cohen,et al.  Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. , 2002, The Journal of clinical investigation.

[181]  D. Kass,et al.  Imbalance Between Xanthine Oxidase and Nitric Oxide Synthase Signaling Pathways Underlies Mechanoenergetic Uncoupling in the Failing Heart , 2002, Circulation research.

[182]  S. Sasayama,et al.  Augmented Expression of Neuronal Nitric Oxide Synthase in the Atria Parasympathetically Decreases Heart Rate During Acute Myocardial Infarction in Rats , 2002, Circulation.

[183]  C. Jones,et al.  Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. , 2001, Clinical science.

[184]  T. Meinertz,et al.  Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.

[185]  J. Beavo,et al.  Upregulation of Phosphodiesterase 1A1 Expression Is Associated With the Development of Nitrate Tolerance , 2001, Circulation.

[186]  C. Berul,et al.  In Vivo Electrophysiologic Studies in Endothelial Nitric Oxide Synthase (eNOS)‐Deficient Mice , 2001, Journal of cardiovascular electrophysiology.

[187]  J. Balligand,et al.  Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes , 2001, Nature Cell Biology.

[188]  Richard T. Lee,et al.  Endothelial Nitric Oxide Synthase Limits Left Ventricular Remodeling After Myocardial Infarction in Mice , 2001, Circulation.

[189]  Maryl R. Johnson,et al.  The Challenge of Rejection and Cardiac Allograft Vasculopathy , 2001, Heart Failure Reviews.

[190]  C. Cooper,et al.  Nitric oxide synthases: structure, function and inhibition , 2001 .

[191]  J. Dalesandro,et al.  Liposome-Mediated Gene Transfection of Endothelial Nitric Oxide Synthase Reduces Endothelial Activation and Leukocyte Infiltration in Transplanted Hearts , 2001, Circulation.

[192]  D. Power,et al.  Coordinated Control of Endothelial Nitric-oxide Synthase Phosphorylation by Protein Kinase C and the cAMP-dependent Protein Kinase* , 2001, The Journal of Biological Chemistry.

[193]  P. Cannon,et al.  Acute Cardiac Allograft Rejection in Nitric OxideSynthase-2−/− and Nitric Oxide Synthase-2+/+ Mice: Effects of Cellular Chimeras on Myocardial Inflammation and Cardiomyocyte Damage and Apoptosis , 2001, Circulation.

[194]  A. Kamkin,et al.  Inotropic response to β‐adrenergic receptor stimulation and anti‐adrenergic effect of ACh in endothelial NO synthase‐deficient mouse hearts , 2001, The Journal of physiology.

[195]  E. Werner,et al.  Formation of a protonated trihydrobiopterin radical cation in the first reaction cycle of neuronal and endothelial nitric oxide synthase detected by electron paramagnetic resonance spectroscopy , 2001, JBIC Journal of Biological Inorganic Chemistry.

[196]  T. Yamashita,et al.  Endothelial NO Synthase Overexpression Inhibits Lesion Formation in Mouse Model of Vascular Remodeling , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[197]  R. Cartier,et al.  CORONARY ARTERY ENDOTHELIAL DYSFUNCTION AFTER ISCHEMIA-REPERFUSION AND ACUTE UNTREATED REJECTION IN A CANINE HETEROTOPIC HEART TRANSPLANTATION MODEL , 2001, Transplantation.

[198]  H Shimokawa,et al.  Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. , 2000, The Journal of clinical investigation.

[199]  A. Takeshita,et al.  Different Vasculoprotective Roles of NO Synthase Isoforms in Vascular Lesion Formation in Mice , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[200]  Y. Watanabe,et al.  Inhibition of neuronal nitric-oxide synthase by calcium/ calmodulin-dependent protein kinase IIalpha through Ser847 phosphorylation in NG108-15 neuronal cells. , 2000, The Journal of biological chemistry.

[201]  R. D. Rudic,et al.  Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. , 2000, The Journal of clinical investigation.

[202]  V. Miller,et al.  Gene transfer of endothelial nitric oxide synthase to pulmonary allografts: impact on acute rejection , 2000, Transplant international : official journal of the European Society for Organ Transplantation.

[203]  N. Blau,et al.  Tetrahydrobiopterin biosynthesis, regeneration and functions. , 2000, The Biochemical journal.

[204]  K. Takeda,et al.  Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes. , 2000, Journal of the American College of Cardiology.

[205]  P. Huang,et al.  Modulation of mouse cardiac function in vivo by eNOS and ANP. , 2000, American journal of physiology. Heart and circulatory physiology.

[206]  H. Granger,et al.  Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol. , 2000, The Journal of pharmacology and experimental therapeutics.

[207]  C. Krebs,et al.  Formation of a pterin radical in the reaction of the heme domain of inducible nitric oxide synthase with oxygen. , 1999, Biochemistry.

[208]  R. Aebersold,et al.  Identification of Flow-dependent Endothelial Nitric-oxide Synthase Phosphorylation Sites by Mass Spectrometry and Regulation of Phosphorylation and Nitric Oxide Production by the Phosphatidylinositol 3-Kinase Inhibitor LY294002* , 1999, The Journal of Biological Chemistry.

[209]  K. Pritchard,et al.  Tetrahydrobiopterin-dependent Inhibition of Superoxide Generation from Neuronal Nitric Oxide Synthase* , 1999, The Journal of Biological Chemistry.

[210]  R. Busse,et al.  Signal transduction of eNOS activation. , 1999, Cardiovascular research.

[211]  H. Yokokura,et al.  Regulation of Neuronal Nitric-oxide Synthase by Calmodulin Kinases* , 1999, The Journal of Biological Chemistry.

[212]  R. Busse,et al.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.

[213]  W. Sessa,et al.  Regulation of endothelium-derived nitric oxide production by the protein kinase Akt , 1999, Nature.

[214]  P. Huang,et al.  Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. , 1999, American journal of physiology. Heart and circulatory physiology.

[215]  V. Miller,et al.  Distribution and function of recombinant endothelial nitric oxide synthase in transplanted hearts. , 1999, Cardiovascular research.

[216]  J. Stamler,et al.  Regulation of ryanodine receptors by reactive nitrogen species. , 1999, Biochemical pharmacology.

[217]  O. Griffith,et al.  Mammalian nitric oxide synthases. , 1999, Advances in enzymology and related areas of molecular biology.

[218]  P. Mcconnell,et al.  Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption. , 1999, Circulation research.

[219]  V. J. Venema,et al.  VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. , 1999, Biochemical and biophysical research communications.

[220]  R. Fischmeister,et al.  Muscarinic and β-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase , 1999, Nature Medicine.

[221]  D. Bredt,et al.  Nitric oxide synthase in cardiac sarcoplasmic reticulum. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[222]  T. Poulos,et al.  Crystal Structure of Constitutive Endothelial Nitric Oxide Synthase A Paradigm for Pterin Function Involving a Novel Metal Center , 1998, Cell.

[223]  J. Balligand,et al.  The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. , 1998, The Journal of clinical investigation.

[224]  H. Drexler,et al.  Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. , 1998, Journal of the American College of Cardiology.

[225]  R. Virmani,et al.  Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. , 1998, The Journal of clinical investigation.

[226]  D. Harrison,et al.  Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[227]  W. Mayhan,et al.  Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity. , 1997, The American journal of physiology.

[228]  D. Pinsky,et al.  Mechanical transduction of nitric oxide synthesis in the beating heart. , 1997, Circulation research.

[229]  B. Prendergast,et al.  Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. , 1997, Circulation.

[230]  J. Vilaine,et al.  Time course of coronary endothelial dysfunction in acute untreated rejection after heterotopic heart transplantation. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[231]  J. Brewer,et al.  GTP Cyclohydrolase I Feedback Regulatory Protein Is a Pentamer of Identical Subunits , 1997, The Journal of Biological Chemistry.

[232]  D. Wink,et al.  The Nitric Oxide/Superoxide Assay , 1997, The Journal of Biological Chemistry.

[233]  S. Snyder,et al.  Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[234]  E. Werner,et al.  Tetrahydrobiopterin-free neuronal nitric oxide synthase: evidence for two identical highly anticooperative pteridine binding sites. , 1996, Biochemistry.

[235]  M. Wolin,et al.  Role of nitric oxide and its interaction with superoxide in the suppression of cardiac muscle mitochondrial respiration. Involvement in response to hypoxia/reoxygenation. , 1996, Circulation.

[236]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[237]  J. Stamler,et al.  Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols , 1996, The Journal of general physiology.

[238]  S. Rajagopalan,et al.  Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug. , 1996, The Journal of clinical investigation.

[239]  L. Kobzik,et al.  Endothelial Nitric Oxide Synthase Targeting to Caveolae , 1996, The Journal of Biological Chemistry.

[240]  T. Bonner,et al.  Purification and Cloning of the GTP Cyclohydrolase I Feedback Regulatory Protein, GFRP* , 1996, The Journal of Biological Chemistry.

[241]  I. Rodrı́guez-Crespo,et al.  Endothelial Nitric-oxide Synthase , 1996, The Journal of Biological Chemistry.

[242]  E. Sheta,et al.  Neuronal nitric oxide synthase, a modular enzyme formed by convergent evolution: structure studies of a cysteine thiolate‐liganded heme protein that hydroxylates L‐arginine to produce NO as a cellular signal , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[243]  D. Bredt,et al.  Interaction of Nitric Oxide Synthase with the Postsynaptic Density Protein PSD-95 and α1-Syntrophin Mediated by PDZ Domains , 1996, Cell.

[244]  D. Kass,et al.  Minimal role of nitric oxide in basal coronary flow regulation and cardiac energetics of blood‐perfused isolated canine heart. , 1996, The Journal of physiology.

[245]  P. Tsao,et al.  Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. , 1996, Circulation.

[246]  U. Förstermann,et al.  Expression of inducible nitric oxide synthase in failing and non-failing human heart. , 1996, Journal of molecular and cellular cardiology.

[247]  J. Balligand,et al.  Glucocorticoids Increase Osteopontin Expression in Cardiac Myocytes and Microvascular Endothelial Cells , 1995, The Journal of Biological Chemistry.

[248]  W. Paulus,et al.  Paracrine coronary endothelial control of left ventricular function in humans. , 1995, Circulation.

[249]  J. Balligand,et al.  Nitric Oxide-dependent Parasympathetic Signaling Is Due to Activation of Constitutive Endothelial (Type III) Nitric Oxide Synthase in Cardiac Myocytes (*) , 1995, The Journal of Biological Chemistry.

[250]  J. Ahlner,et al.  Mechanisms of action of nitrates , 1994, Cardiovascular Drugs and Therapy.

[251]  J. Bauer,et al.  Mechanisms of nitrate tolerance , 1994, Cardiovascular Drugs and Therapy.

[252]  S Moncada,et al.  Nitric oxide synthases in mammals. , 1994, The Biochemical journal.

[253]  Y. Hattori,et al.  GTP cyclohydrolase I mRNA is induced by LPS in vascular smooth muscle: characterization, sequence and relationship to nitric oxide synthase. , 1993, Biochemical and biophysical research communications.

[254]  M. Edelstein,et al.  Biosynthesis of tetrahydrobiopterin by de novo and salvage pathways in adrenal medulla extracts, mammalian cell cultures, and rat brain in vivo. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[255]  A. Hale,et al.  Cardiomyocyte-targeted overexpression of GTP cyclohydrolase-1 increases nNOS activity and hastens myocardial relaxation , 2011 .

[256]  Christian Jung,et al.  Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. , 2010, Cardiovascular research.

[257]  T. Adachi Modulation of vascular sarco/endoplasmic reticulum calcium ATPase in cardiovascular pathophysiology. , 2010, Advances in pharmacology.

[258]  J. Hare,et al.  Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance. , 2009, Frontiers in bioscience.

[259]  P. Massart,et al.  Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy. , 2002, American journal of physiology. Heart and circulatory physiology.

[260]  S. Kawachi,et al.  Role of nitric oxide in the regulation of acute and chronic inflammation. , 2000, Antioxidants & redox signaling.

[261]  D. Bredt,et al.  Regulation of neuronal nitric oxide synthase through alternative transcripts. , 1997, Developmental neuroscience.

[262]  B. Masters,et al.  Erratum: Neuronal nitric oxide synthase, a modular enzyme formed by convergent evolution: Structure studies of a cysteine thiolate-liganded heme protein that hydroxylates L-arginine to produce NO· as a cellular signal (The FASEB Journal (1996) 10 (552-558)) , 1996 .

[263]  J. Vane,et al.  Tetrahydrobiopterin synthesis is induced by LPS in vascular smooth muscle and is rate-limiting for nitric oxide production. , 1993, Advances in experimental medicine and biology.